<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="24741" end="24745" sStart="24726" offset="15" sid="r7.1.use.v.0739" wn="1" wnkey="use%2:34:01::" text="Example 3 also used a ranking method after LOCF for a secondary analysis." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="13246" end="13250" sStart="null" offset="20" sid="r11.true.j.0107" wn="1" wnkey="true%3:00:00::" text="The same is true for the latter: patients responding to treatment tend to continue in the study, while patients failing to respond tend to drop out prematurely." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3121" end="3125" sStart="null" offset="0" sid="null" wn="3" wnkey="time%1:28:00::" text="Listed reasons (and number of patients) for missing exercise &lt;b&gt;time&lt;/b&gt; data at 24 weeks were: 'exercise test not done due to death' (n = 30), 'exercise testing contraindicated' (n = 9), and 'exercise test not done for other reasons' (n = 10)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3121" end="3125" sStart="null" offset="0" sid="null" wn="7" wnkey="time%1:28:03::" text="Listed reasons (and number of patients) for missing exercise &lt;b&gt;time&lt;/b&gt; data at 24 weeks were: 'exercise test not done due to death' (n = 30), 'exercise testing contraindicated' (n = 9), and 'exercise test not done for other reasons' (n = 10)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3121" end="3125" sStart="null" offset="0" sid="null" wn="2" wnkey="time%1:28:05::" text="Listed reasons (and number of patients) for missing exercise &lt;b&gt;time&lt;/b&gt; data at 24 weeks were: 'exercise test not done due to death' (n = 30), 'exercise testing contraindicated' (n = 9), and 'exercise test not done for other reasons' (n = 10)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3121" end="3125" sStart="null" offset="0" sid="null" wn="8" wnkey="time%1:28:04::" text="Listed reasons (and number of patients) for missing exercise &lt;b&gt;time&lt;/b&gt; data at 24 weeks were: 'exercise test not done due to death' (n = 30), 'exercise testing contraindicated' (n = 9), and 'exercise test not done for other reasons' (n = 10)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3121" end="3125" sStart="null" offset="0" sid="null" wn="7" wnkey="time%1:28:03::" text="Listed reasons (and number of patients) for missing exercise &lt;b&gt;time&lt;/b&gt; data at 24 weeks were: 'exercise test not done due to death' (n = 30), 'exercise testing contraindicated' (n = 9), and 'exercise test not done for other reasons' (n = 10)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3121" end="3125" sStart="null" offset="0" sid="null" wn="2" wnkey="time%1:28:05::" text="Listed reasons (and number of patients) for missing exercise &lt;b&gt;time&lt;/b&gt; data at 24 weeks were: 'exercise test not done due to death' (n = 30), 'exercise testing contraindicated' (n = 9), and 'exercise test not done for other reasons' (n = 10)." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="26209" end="26215" sStart="null" offset="143" sid="r11.strong.j.0538" wn="1" wnkey="strong%3:00:00::" text="In both cases, the validity of the various models or ranking rules requires an examination of the missing data information and strong faith in the reasons given for the patients' withdrawal." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="22916" end="22922" sStart="null" offset="24" sid="r11.strong.j.0827" wn="2" wnkey="strong%5:00:00:intense:00" text="Since LOCF requires the strong assumption of stability, the more it imputes the more bias it introduces if the assumption of stability does not hold." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1468-6708-3-4.anc" start="26540" end="26543" sStart="null" offset="0" sid="null" wn="3" wnkey="say%2:32:03::" text="They attempt to follow the ITT principle (but with missing data) to answer question (i) above, hoping that the dropouts can hypothetically be removed by, &lt;b&gt;say&lt;/b&gt;, a truly ITT design, or by successfully using concurrent treatments for intolerable side effects without affecting the efficacy of the study medication." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="29422" end="29433" sStart="null" offset="143" sid="r11.recommend.v.0376" wn="1" wnkey="recommend%2:32:01::" text="As has been noted in the ICH-E9 guideline [ 9 ] , 'no universally applicable methods of handling missing values can be recommended." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="17569" end="17580" sStart="null" offset="73" sid="r11.recommend.v.0375" wn="1" wnkey="recommend%2:32:01::" text="Since no missing data would occur, the design of (b) is highly recommended for all trials if at all possible." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3895" end="3899" sStart="null" offset="211" sid="r7.poor.j.0553" wn="4" wnkey="poor%3:00:02::" text="'Twenty-four failed to complete the (six-month) trial, and thus were not included for analysis because of 1) withdrawal for symptomatic adverse effects, 2) lack of response, and 3) poor compliance." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="2794" end="2798" sStart="null" offset="137" sid="r7.poor.j.0618" wn="5" wnkey="poor%5:00:00:insufficient:00" text="If subsequent tests were not performed, whatever the reason, or performed although compliance between tests had been poor, the last exercise time value obtained while compliance was good was carried forward." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="3895" end="3899" sStart="null" offset="211" sid="r7.poor.j.0553" wn="5" wnkey="poor%5:00:00:insufficient:00" text="'Twenty-four failed to complete the (six-month) trial, and thus were not included for analysis because of 1) withdrawal for symptomatic adverse effects, 2) lack of response, and 3) poor compliance." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="5072" end="5076" sStart="null" offset="152" sid="r7.poor.j.0912" wn="5" wnkey="poor%5:00:00:insufficient:00" text="The authors excluded from the analysis the other 24 patients who withdrew early because of adverse effects, lack of response or poor compliance." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="1520" end="1524" sStart="null" offset="142" sid="r7.poor.j.0376" wn="5" wnkey="poor%5:00:00:insufficient:00" text="'The remaining patients were excluded from the analysis of blood pressure (BP) data because of major protocol violations, poor compliance with medical visits, or withdrawal because of adverse events." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="8941" end="8951" sStart="null" offset="119" sid="r10.particular.j.0457" wn="2" wnkey="particular%5:00:02:specific:00" text="The former 80% is a wrong summary number; the latter is an estimate of the quantity of interest with a particular assumption about the missing data." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="7734" end="7744" sStart="null" offset="25" sid="r10.particular.j.0397" wn="1" wnkey="particular%5:00:00:specific:00" text="That is, when no particular information was available, we may assume that the same proportion of patients (80%) among the 24 (d)dropouts would have also responded, had they completed six months." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="13761" end="13771" sStart="null" offset="8" sid="r10.particular.j.0184" wn="1" wnkey="particular%5:00:00:specific:00" text="When no particular information is known about the missing data, we are essentially assuming that the dropouts are not much different from the completers." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-4.anc" start="28745" end="28749" sStart="null" offset="0" sid="null" wn="1" wnkey="part%1:24:00::" text="Techniques used for analyzing observational studies should be applied to this &lt;b&gt;part&lt;/b&gt; of comparison [ 28 ] . Generally speaking, in an observational study, bias can only be reduced but not entirely eliminated by methods of adjustment or matching." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1468-6708-3-4.anc" start="28745" end="28749" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="Techniques used for analyzing observational studies should be applied to this &lt;b&gt;part&lt;/b&gt; of comparison [ 28 ] . Generally speaking, in an observational study, bias can only be reduced but not entirely eliminated by methods of adjustment or matching." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="9509" end="9514" sStart="null" offset="19" sid="r9.paper.n.0241" wn="5" wnkey="paper%1:10:02::" text="Unfortunately, the paper did not give the number of dropouts according to their treatment groups." />
    <s path="[OANC]/data/written_2/technical/biomed/1468-6708-3-4.anc" start="7224" end="7229" sStart="null" offset="156" sid="r9.paper.n.0502" wn="5" wnkey="paper%1:10:02::" text="Of course, we know that (b) is unrealistic since some people withdrew because of lack of response and some because of side effects, but the paper did not provide the exact numbers." />
  </sentences>
</list>